IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 261 - 270 of 323 for "Peter Voisey" with applied filters

News & Analysis

GSK Stockmann in Luxembourg reinforces investment funds practice with Dr Marcel Bartnik

02 January 2020 by GSK

GSK Stockmann in Luxembourg reinforces its investment funds practice with the hiring of Dr Marcel Bartnik as local partner as of January 2020.
News & Analysis

GSK Stockmann advised on the first real blockchain securities transaction

25 March 2019 by GSK

In mid-January 2019, GSK Stockmann advised on Germany’s first-ever issuance of securities originally carried out as a blockchain transaction. Commerzbank AG, Continental AG and Siemens AG were involved in the transaction.
News & Analysis

2019 M&A Report: Luxembourg

01 March 2019 by Marcus Peter, GSK Stockmann (Luxembourg)

2018 has once again shown a growing trend in M&A transactions with a view to Luxembourg-based target entities as well as acquisitions outside of Luxembourg that were started using a Luxembourg structure. Luxembourg-based targets are typically not the centre of high-profile M&A targets.
News & Analysis

GSK Stockmann in Luxembourg advises China Merchants Bank on its launch of their first European-based investment fund

04 January 2019 by GSK

GSK Stockmann’s Luxembourg office has advised China Merchants Bank (CMB) on its launch of CMB Evergreen SA, SICAV-SIF, a Luxembourg investment fund and being the first European-based investment fund of CMB.
News & Analysis

IFLR 2018 M&A Report: Luxembourg

19 December 2018 by GSK Stockmann

IFLR 2018 M&A Report: Luxembourg
News & Analysis

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2018

09 October 2018 by GSK

The Chinese Outbound Investment Guide 2018 has been published by International Financial Law Review (IFLR) and looks at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.
News & Analysis

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2018

18 July 2018 by GSK

The Chinese Outbound Investment Guide 2018 has been published by International Financial Law Review (IFLR) and looks at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.
News & Analysis

CYPRUS: Waiver of right to arbitrate by resorting to litigation

02 July 2018 by Soteris Pittas & Co - Cyprus

BRIEFING: Limassol, 2 July, 2018
News & Analysis

GSK Stockmann in Luxembourg advises EQT regarding the merger of Sivantos and Widex to create global hearing aid leader

17 May 2018 by GSK

GSK Stockmann’s Luxembourg office is advising EQT pertaining to the merger of the two leading hearing aid companies. With a comprehensive, multi-channel sales and distribution platform in more than 125 markets and combined revenues of approximately EUR 1.6 billion the new hearing aid company will become a top-three contender globally.
News & Analysis

GSK Stockmann advises Corestate Capital Group on the acquisition of five major real estate projects

12 January 2018 by GSK

GSK Stockmann provided legal counsel to Corestate Capital Group on the acquisition of a package of five large-scale projects with a residential focus in a forward (asset) deal. The five objects were acquired for the real estate umbrella fund launched by Universal-Investment on behalf of the Bayrische Versorgungskammer on its Luxembourg-based AIF platform. Seller is the project developer CG Gruppe AG.
Load more